In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 106595-91-9, name is 4-Benzyl-1,3-dihydroquinoxalin-2-one, introducing its new discovery. Recommanded Product: 4-Benzyl-1,3-dihydroquinoxalin-2-one
The sp3-C-H peroxidation of 3,4-dihydro-1,4-benzoxazin-2-ones was achieved under mild and simple catalyst-free reaction conditions. A range of biologically important alkylated benzoxazinone peroxides are synthesized in high yield with a good functional group tolerance. The C(sp3)-OO bond was constructed efficiently and could be further converted into C(sp3)-C(sp3), C(sp3)-C(sp2), C(sp3)-C(sp), C-P and CO bonds by late-stage functional group transformations.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 106595-91-9, and how the biochemistry of the body works.Recommanded Product: 4-Benzyl-1,3-dihydroquinoxalin-2-one
Reference£º
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1914 | ChemSpider